Isavuconazole brain penetration in cerebral aspergillosis.

Lamoth, F; Mercier, T; André, P; Pagani, J L; Pantet, O; Maduri, R; Guery, B; Decosterd, L A

Lamoth, F; Mercier, T; André, P; Pagani, J L; Pantet, O; Maduri, R; Guery, B; Decosterd, L A.

Afiliación

Lamoth F; Service of Infectious Diseases, Lausanne University Hospital, Lausanne, Switzerland.
Mercier T; Institute of Microbiology, Lausanne University Hospital, Lausanne, Switzerland.
André P; Service and Laboratory of Clinical Pharmacology, University Hospital, Lausanne, Switzerland.
Pagani JL; Service and Laboratory of Clinical Pharmacology, University Hospital, Lausanne, Switzerland.
Pantet O; Service of Intensive Care Medicine, Lausanne University Hospital, Lausanne, Switzerland.
Maduri R; Service of Intensive Care Medicine, Lausanne University Hospital, Lausanne, Switzerland.
Guery B; Department of Clinical Neurosciences, Service of Neurosurgery, Lausanne University Hospital, Lausanne, Switzerland.
Decosterd LA; Service of Infectious Diseases, Lausanne University Hospital, Lausanne, Switzerland.

J Antimicrob Chemother ; 74(6): 1751-1753, 2019 06 01.

Article en En | MEDLINE | ID: mdl-30753519

Asunto(s)

Antifúngicos/farmacocinética; Encefalitis Infecciosa/tratamiento farmacológico; Encefalitis Infecciosa/microbiología; Neuroaspergilosis/tratamiento farmacológico; Nitrilos/farmacocinética; Piridinas/farmacocinética; Triazoles/farmacocinética; Humanos; Permeabilidad; Distribución Tisular

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piridinas / Triazoles / Neuroaspergilosis / Encefalitis Infecciosa / Antifúngicos / Nitrilos Límite: Humans Idioma: En Revista: J Antimicrob Chemother Año: 2019 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google